NASDAQ : AXSM
Axsome Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 136.01 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 7.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Axsome Therapeutics, Inc. (AXSM) reported revenue of 865.27M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 865.27M | 638.50M | 385.69M | 270.60M | 50.04M | |
| Cost of Revenue | 58.42M | 47.48M | 33.30M | 26.07M | 4.10M | |
| Gross Profit | 806.85M | 591.02M | 352.39M | 244.53M | 45.94M | |
| Selling, General & Admin | 765.54M | 570.60M | 411.36M | 323.12M | 159.25M | 66.65M |
| Research & Development | 198.31M | 183.28M | 187.08M | 97.94M | 57.95M | 58.06M |
| Amortization of Goodwill & Intangibles | 6.38M | 6.38M | 6.39M | 6.38M | 4.14M | |
| Operating Expenses | 970.23M | 760.25M | 604.83M | 427.44M | 221.34M | 124.71M |
| Operating Income | -163.38M | -169.24M | -252.44M | -182.91M | -175.40M | -124.71M |
| Interest Expense | -14.99M | -15.93M | -21.58M | -20.03M | -9.66M | -5.70M |
| Interest & Investment Income | 9.37M | 9.37M | 15.01M | 13.58M | 2.32M | |
| EBT Excluding Unusual Items | -169.00M | -175.79M | -259.01M | -189.36M | -182.74M | -130.40M |
| Merger & Restructuring Charges | -1.10M | |||||
| Other Unusual Items | 12.35M | -7.91M | -28.12M | -48.92M | -3.30M | |
| Pretax Income | -156.65M | -183.70M | -287.13M | -238.28M | -187.13M | -130.40M |
| Income Tax Expense | 646.00K | -530.00K | 85.00K | 960.00K | ||
| Net Income | -157.29M | -183.17M | -287.22M | -239.24M | -187.13M | -130.40M |
| Net Income to Common | -157.29M | -183.17M | -287.22M | -239.24M | -187.13M | -130.40M |
| Shares Outstanding (Basic) | 51.52M | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M |
| Shares Outstanding (Diluted) | 51.52M | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M |
| EPS (Basic) | -3.05 | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| EPS (Diluted) | -3.05 | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
| Free Cash Flow | -93.89M | -128.68M | -145.66M | -117.21M | -108.53M | |
| Free Cash Flow Per Share | -1.89 | -2.69 | -3.21 | -2.88 | -2.88 | |
| Gross Margin | 93.25% | 92.56% | 91.36% | 90.37% | 91.81% | |
| Operating Margin | -18.88% | -26.51% | -65.45% | -67.59% | -350.54% | |
| Profit Margin | -18.18% | -28.69% | -74.47% | -88.41% | -373.99% | |
| Free Cash Flow Margin | -14.70% | -33.36% | -53.83% | -234.25% | ||
| EBITDA | -152.45M | -160.17M | -244.48M | -176.07M | -171.00M | -124.63M |
| EBITDA Margin | -17.62% | -25.09% | -63.39% | -65.07% | ||
| D&A For EBITDA | 10.94M | 9.06M | 7.96M | 6.83M | 4.40M | 76.00K |
| EBIT | -163.38M | -169.24M | -252.44M | -182.91M | -175.40M | -124.71M |
| EBIT Margin | -18.88% | -26.51% | -65.45% | -67.59% | ||
| Revenue as Reported | 865.27M | 638.50M | 385.69M | 270.60M | 50.04M | |
| Advertising Expenses | 167.10M | 101.20M | 100.30M | 35.30M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 313.86M | 322.93M | 315.35M | 386.19M | 200.84M | 86.47M |
| Cash & Short-Term Investments | 313.86M | 322.93M | 315.35M | 386.19M | 200.84M | 86.47M |
| Receivables | 343.11M | 224.46M | 142.00M | 94.82M | 37.70M | |
| Inventory | 42.58M | 27.94M | 15.73M | 15.13M | 4.32M | |
| Prepaid Expenses | 25.08M | 13.65M | 11.98M | 8.12M | 2.78M | 45.29K |
| Total Current Assets | 724.64M | 588.99M | 485.06M | 504.26M | 245.64M | 86.52M |
| Property, Plant & Equipment | 19.23M | 21.42M | 5.97M | 7.62M | 1.14M | 944.01K |
| Goodwill | 12.04M | 12.04M | 12.04M | 12.04M | 10.31M | |
| Other Intangible Assets | 35.75M | 40.52M | 46.89M | 53.29M | 59.66M | |
| Other Long-Term Assets | 35.12M | 26.84M | 18.53M | 11.03M | 14.72M | 322.91K |
| Total Assets | 826.77M | 689.80M | 568.50M | 588.24M | 331.48M | 87.79M |
| Accounts Payable | 96.08M | 65.54M | 72.00M | 40.68M | 38.60M | 13.15M |
| Accrued Expenses | 331.76M | 230.21M | 145.61M | 90.50M | 51.63M | 9.30M |
| Short-Term Debt | 70.00M | 70.00M | ||||
| Current Portion of Leases | 663.00K | 2.98M | 3.26M | 1.27M | 425.00K | 620.67K |
| Current Income Taxes Payable | 101.00K | 960.00K | ||||
| Other Current Liabilities | 11.22M | 10.01M | 8.29M | 6.41M | 5.90M | |
| Total Current Liabilities | 509.72M | 378.84M | 230.10M | 138.85M | 96.56M | 23.07M |
| Long-Term Debt | 118.07M | 117.75M | 180.71M | 178.07M | 94.26M | 49.09M |
| Long-Term Leases | 29.94M | 27.39M | 8.99M | 7.04M | ||
| Other Long-Term Liabilities | 63.61M | 77.54M | 91.68M | 73.30M | 31.10M | |
| Total Liabilities | 721.34M | 601.51M | 511.48M | 397.26M | 221.92M | 72.15M |
| Common Stock | 5.00K | 5.00K | 5.00K | 5.00K | 4.00K | 3.78K |
| Additional Paid-In Capital | 1.54B | 1.39B | 1.18B | 1.03B | 705.88M | 424.83M |
| Retained Earnings | -1.43B | -1.31B | -1.12B | -835.57M | -596.33M | -409.20M |
| Shareholders' Equity | 105.43M | 88.30M | 57.02M | 190.98M | 109.56M | 15.63M |
| Total Liabilities & Equity | 826.77M | 689.80M | 568.50M | 588.24M | 331.48M | 87.79M |
| Total Debt | 218.67M | 218.11M | 192.96M | 186.37M | 94.68M | 49.71M |
| Net Cash (Debt) | 95.19M | 104.82M | 122.40M | 199.82M | 106.16M | 36.76M |
| Net Cash Per Share | 1.85 | 2.11 | 2.55 | 4.40 | 2.61 | 0.98 |
| Filing Date Shares Outstanding | 52.58M | 51.15M | 48.77M | 47.37M | 43.52M | 38.48M |
| Total Common Shares Outstanding | 52.58M | 50.88M | 48.67M | 47.35M | 43.50M | 37.82M |
| Working Capital | 214.92M | 210.15M | 254.96M | 365.41M | 149.08M | 63.45M |
| Book Value Per Share | 2.01 | 1.74 | 1.17 | 4.03 | 2.52 | 0.41 |
| Tangible Book Value | 57.64M | 35.73M | -1.92M | 125.65M | 39.59M | 15.63M |
| Tangible Book Value Per Share | 1.10 | 0.70 | -0.04 | 2.65 | 0.91 | 0.41 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| Depreciation & Amortization | 9.06M | 7.96M | 6.83M | 4.40M | 76.00K | |
| Other Amortization | 1.30M | 2.64M | 2.57M | 1.48M | 1.08M | |
| Stock-Based Compensation | 93.75M | 85.22M | 62.62M | 37.73M | 20.80M | |
| Other Operating Activities | 8.71M | 29.51M | 50.37M | 3.34M | -103.00K | |
| Change in Accounts Receivable | -82.46M | -47.18M | -57.12M | -37.70M | ||
| Change in Inventory | -10.66M | 744.00K | -8.16M | -1.33M | ||
| Change in Accounts Payable | -6.46M | 31.32M | 2.07M | 25.46M | -355.00K | |
| Change in Other Net Operating Assets | 76.53M | 48.60M | 34.97M | 37.24M | 679.00K | |
| Operating Cash Flow | -93.41M | -128.41M | -145.08M | -116.51M | -108.23M | |
| Capital Expenditures | -480.00K | -270.00K | -582.00K | -702.00K | -308.00K | |
| Cash Acquisitions | -53.00M | |||||
| Investing Cash Flow | -480.00K | -270.00K | -582.00K | -53.70M | -308.00K | |
| Long-Term Debt Issued | 330.00M | 85.00M | 45.00M | |||
| Long-Term Debt Repaid | -334.11M | -990.00K | ||||
| Total Debt Repaid | -334.11M | -990.00K | ||||
| Net Debt Issued (Repaid) | -4.11M | -990.00K | 85.00M | 45.00M | ||
| Issuance of Common Stock | 127.46M | 71.46M | 271.17M | 250.01M | 11.84M | |
| Repurchase of Common Stock | -7.11M | -3.95M | -1.83M | -532.00K | -176.00K | |
| Other Financing Activities | -14.78M | -8.68M | -23.32M | -9.90M | -532.00K | |
| Financing Cash Flow | 101.47M | 57.84M | 331.01M | 284.58M | 11.13M | |
| Net Cash Flow | 7.58M | -70.84M | 185.35M | 114.37M | -97.40M | |
| Free Cash Flow | -93.89M | -128.68M | -145.66M | -117.21M | -108.53M | |
| Free Cash Flow Margin | -14.70% | -33.36% | -53.83% | -234.25% | ||
| Free Cash Flow Per Share | -1.89 | -2.69 | -3.21 | -2.88 | -2.88 | |
| Levered Free Cash Flow | -29.42M | -38.10M | -87.21M | -43.82M | -59.52M | |
| Unlevered Free Cash Flow | -20.77M | -27.25M | -77.26M | -39.26M | -57.04M | |
| Cash Interest Paid | 14.63M | 19.69M | 16.73M | 7.69M | 4.62M | |
| Change in Working Capital | -23.06M | 33.48M | -28.24M | 23.67M | 324.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.15B | 9.21B | 4.10B | 3.77B | 3.35B | 1.42B |
| Enterprise Value | 7.06B | 9.10B | 3.97B | 3.54B | 3.22B | 1.36B |
| Last Close Price | 136.01 | 182.64 | 84.61 | 79.59 | 77.13 | 37.78 |
| PS Ratio | 8.26 | 14.42 | 10.63 | 13.92 | 66.94 | |
| PB Ratio | 67.82 | 104.28 | 71.92 | 19.72 | 30.57 | 91.10 |
| P/TBV Ratio | 124.06 | 257.66 | 29.97 | 84.61 | 91.10 | |
| EV/Sales Ratio | 8.15 | 14.25 | 10.28 | 13.06 | 64.28 | |
| Debt / Equity Ratio | 2.07 | 2.47 | 3.38 | 0.98 | 0.86 | 3.18 |
| Net Debt / Equity Ratio | -0.90 | -1.19 | -2.15 | -1.05 | -0.97 | -2.35 |
| Net Debt / EBITDA Ratio | 0.62 | 0.65 | 0.50 | 1.14 | 0.62 | 0.29 |
| Net Debt / FCF Ratio | 1.12 | 0.95 | 1.37 | 0.91 | 0.34 | |
| Asset Turnover | 1.16 | 1.01 | 0.67 | 0.59 | 0.24 | |
| Inventory Turnover | 1.76 | 2.17 | 2.16 | 2.68 | ||
| Quick Ratio | 1.29 | 1.45 | 1.99 | 3.46 | 2.47 | 3.75 |
| Current Ratio | 1.42 | 1.55 | 2.11 | 3.63 | 2.54 | 3.75 |
| Return on Equity (ROE) | -175.59% | -252.12% | -231.63% | -159.21% | -298.97% | -201.51% |
| Return on Assets (ROA) | -13.65% | -16.81% | -27.28% | -24.86% | -52.30% | -56.91% |
| Return on Capital Employed (ROCE) | -51.50% | -54.40% | -74.60% | -40.70% | -74.70% | -192.70% |
| Earnings Yield | -2.24% | -1.99% | -7.00% | -6.35% | -5.59% | -9.16% |
| FCF Yield | -1.01% | -1.02% | -3.14% | -3.87% | -3.50% | -7.62% |
| Buyback Yield / Dilution | -4.67% | -3.82% | -5.48% | -11.73% | -8.07% | -1.11% |